Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$466M |
| 2 |
Applovin
APP
|
+$349M |
| 3 |
General Dynamics
GD
|
+$272M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$257M |
| 5 |
iShares Global Infrastructure ETF
IGF
|
+$222M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ANSS
Ansys
ANSS
|
+$396M |
| 2 |
HES
Hess
HES
|
+$383M |
| 3 |
Apple
AAPL
|
+$362M |
| 4 |
NVIDIA
NVDA
|
+$298M |
| 5 |
Microsoft
MSFT
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.46% |
| 2 | Financials | 12.23% |
| 3 | Consumer Discretionary | 9.45% |
| 4 | Communication Services | 8.8% |
| 5 | Healthcare | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4101
Rafael Holdings
RFL
$101M
| $115K | ﹤0.01% |
84,476
+23,786
| +39% | +$40K |
|
4102
ECARX Holdings
ECX
$417M
| $115K | ﹤0.01% |
57,073
-19,983
| -26% | -$35.4K |
|
4103
PDS Biotechnology
PDSB
$38.4M
| $115K | ﹤0.01% |
113,472
-8,743
| -7% | -$10.3K |
|
|
OKYO
4104
OKYO Pharma
OKYO
$88.2M
| $114K | ﹤0.01% |
+57,158
| New | +$146K |
|
4105
The ONE Group
STKS
$56.2M
| $114K | ﹤0.01% |
38,533
-15,837
| -29% | -$49.7K |
|
4106
Skye Bioscience
SKYE
$20M
| $114K | ﹤0.01% |
29,004
| – | – |
|
4107
Adicet Bio
ACET
$85.2M
| $114K | ﹤0.01% |
8,773
| – | – |
|
4108
PSQ Holdings
PSQH
$13.9M
| $113K | ﹤0.01% |
3,935
-1,075
| -21% | -$32.7K |
|
|
IRD
4109
Opus Genetics
IRD
$306M
| $113K | ﹤0.01% |
68,228
| – | – |
|
|
MHN
4110
DELISTED
BlackRock MuniHoldings New Yrok Quality Fund
MHN
| $112K | ﹤0.01% |
10,972
-40
| -0.4% | -$391 |
|
|
AMOD
4111
Alpha Modus Holdings
AMOD
$19.2M
| $112K | ﹤0.01% |
+2,353
| New | +$109K |
|
4112
Acumen Pharmaceuticals
ABOS
$155M
| $111K | ﹤0.01% |
64,954
-208
| -0.3% | -$288 |
|
4113
Grove Collaborative
GROV
$46.2M
| $110K | ﹤0.01% |
73,643
-14,836
| -17% | -$21.6K |
|
|
OSTX
4114
OS Therapies Inc
OSTX
$69.2M
| $110K | ﹤0.01% |
+56,263
| New | +$111K |
|
|
XMAX
4115
XMAX Inc
XMAX
$548M
| $110K | ﹤0.01% |
+19,902
| New | +$59K |
|
|
IMDX
4116
Insight Molecular Diagnostics
IMDX
$150M
| $109K | ﹤0.01% |
32,890
| – | – |
|
|
SELF
4117
Global Self Storage
SELF
$58.3M
| $107K | ﹤0.01% |
21,371
| – | – |
|
|
ARAI
4118
Arrive AI Inc
ARAI
$12.2M
| $106K | ﹤0.01% |
+29,151
| New | +$193K |
|
4119
Cyngn
CYN
$15.3M
| $106K | ﹤0.01% |
+17,587
| New | +$127K |
|
4120
Sutro Biopharma
STRO
$401M
| $106K | ﹤0.01% |
12,212
-4,561
| -27% | -$38.8K |
|
|
GRML
4121
Greenland Mines Ltd
GRML
$29.2M
| $106K | ﹤0.01% |
218,785
+151,583
| +226% | +$131K |
|
4122
Quince Therapeutics
QNCX
$22.9M
| $105K | ﹤0.01% |
324
-63
| -16% | -$21K |
|
|
HIT
4123
Health In Tech Inc
HIT
$72.7M
| $105K | ﹤0.01% |
+32,820
| New | +$78.6K |
|
4124
TechPrecision Corp
TPCS
$47.3M
| $105K | ﹤0.01% |
+19,748
| New | +$94.8K |
|
|
APLT
4125
DELISTED
Applied Therapeutics
APLT
| $105K | ﹤0.01% |
173,715
-1,540
| -0.9% | -$725 |
|
Similar funds
Northern Trust's Q3 2025 Portfolio in Review
As of Q3 2025, Northern Trust held 4,566 positions worth $782B, up 7.5% from $727B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Northern Trust's Q3 2025 filing shows 167 new, 1,770 increased, 2,268 reduced and 144 closed positions. Its largest new stake was Amrize Ltd: 1,020,799 shares worth $49.5M. The largest sale was Ansys, an estimated $396M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.
- Northern Trust's largest Q3 2025 buy was Amrize Ltd: 1,020,799 shares worth $49.5M.
- Northern Trust added most to Chevron in Q3 2025, an estimated $466M increase.
- Northern Trust's biggest Q3 2025 reduction was Apple, cutting an estimated $362M.
- Northern Trust fully exited Ansys in Q3 2025, selling an estimated $396M.
- Northern Trust's ten largest holdings make up 30% of its $782B portfolio in Q3 2025.
- Northern Trust opened 167 new positions and closed 144 in Q3 2025.
- Northern Trust's portfolio value rose 7.5% quarter-over-quarter to $782B.
Based on Northern Trust's 13F filing for Q3 2025, filed 14 Nov 2025.